Mycobacterium tuberculosis, rifapentine, moxifloxacin
Showing 1 - 25 of 1,466
Tuberculosis, Pulmonary Trial in Kaohsiung, Taipei, Taoyuan City (4-month rifapentine-based regimen)
Not yet recruiting
- Tuberculosis, Pulmonary
- 4-month rifapentine-based regimen
-
Kaohsiung, Taiwan
- +3 more
Apr 22, 2021
Tuberculosis Trial in Worldwide (rifapentine, rifapentine and moxifloxacin, control)
Tuberculosis, Pulmonary Trial in China (Short Regimen with Rifapentine 10mg/kg, Standardized Regimen, Short Regimen with
Not yet recruiting
- Tuberculosis, Pulmonary
- Short Regimen with Rifapentine 10mg/kg
- +3 more
-
Guiyang, Guizhou, China
- +5 more
May 28, 2022
HIV-associated Tuberculosis Trial in South Africa, Thailand (Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC,
Not yet recruiting
- HIV-associated Tuberculosis
- Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC
- +3 more
-
Mowbray, Cape Town, Western Cape, South Africa
- +3 more
Nov 18, 2022
Latent Tuberculosis, End Stage Renal Disease, Renal Transplant Candidate for Right Kidney Trial in New Brunswick (Rifapentine)
Not yet recruiting
- Latent Tuberculosis
- +3 more
-
New Brunswick, New JerseyPinki J Bhatt
Jun 6, 2022
Pharmacometrics to Advance Novel Regimens for Drug-resistant
Recruiting
- Multi-drug Resistant Tuberculosis
-
Almaty, Kazakhstan
- +6 more
Nov 1, 2022
Latent Tuberculosis Infection Trial in Taipei (isoniazid and rifapentine)
Recruiting
- Latent Tuberculosis Infection
- isoniazid and rifapentine
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 22, 2022
Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,
Not yet recruiting
- Tuberculosis, Pulmonary
- Other Specified Pulmonary Tuberculosis
- BTZ-043
- +3 more
-
Cape Town, South Africa
- +3 more
Jun 22, 2023
HIV-infected Participants With Latent TB Infection in High TB Burden Country Trial in Thailand (Isoniazid/Rifapentine daily (4
Recruiting
- HIV-infected Participants With Latent TB Infection in High TB Burden Country
- Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6)
- Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)
-
Bangkok, Thailand
- +15 more
Mar 22, 2022
Pulmonology Trial in Taipei (Rifamycin-containing regimen, Rifamycin-free regimen)
Recruiting
- Pulmonology
- Rifamycin-containing regimen
- Rifamycin-free regimen
-
Taipei, TaiwanNational Taiwan University Hospital
Oct 18, 2022
Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)
Not yet recruiting
- Tuberculosis
- Human Immunodeficiency Virus
- Optimised rifamycin
- (no location specified)
Oct 8, 2022
Sensitivity and Specificity of Xpert MTB/RIF Ultra
Not yet recruiting
- Tuberculosis
- (no location specified)
Oct 1, 2023
Tuberculosis, Latent Tuberculosis Infection Trial in Bijie, Linping, Qingzhen (QuantiFERON-TB Gold (QFT) test)
Recruiting
- Tuberculosis
- Latent Tuberculosis Infection
- QuantiFERON-TB Gold (QFT) test
-
Bijie, Guizhou, China
- +4 more
Sep 12, 2023
MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)
Active, not recruiting
- MDR-TB
- Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
- +9 more
-
Addis Ababa, Ethiopia
- +12 more
Oct 12, 2022
Tuberculosis, HIV Trial in Worldwide (Rifapentine (RPT), Isoniazid (INH), Pyridoxine (Vitamin B6))
Completed
- Tuberculosis
- HIV Infections
- Rifapentine (RPT)
- +2 more
-
La Jolla, California
- +44 more
Nov 2, 2021
Tuberculosis, HIV Trial in South Africa (VPM1002 Vaccine, BCG Vaccine, Placebo)
Not yet recruiting
- Tuberculosis
- HIV Infections
- VPM1002 Vaccine
- +2 more
-
Johannesburg, Gauteng, South Africa
- +8 more
Sep 14, 2022
Latent Tuberculosis Infection in Health-care Workers and
Recruiting
- Tuberculosis
- +4 more
- Prevalence of Latent Tuberculosis Infection
-
Roma, ItalyUOSD Allergologia e Immunologia Clinica, Fondazione Policlinico
Mar 1, 2023
Mycobacterium Avium Complex Trial in Baltimore (Azithromycin)
Recruiting
- Mycobacterium Avium Complex
-
Baltimore, MarylandJohns Hopkins University School of Medicine
Mar 7, 2022
Tuberculosis, Pulmonary, Tuberculosis Infection Trial in Worldwide (Rifabutin, Delamanid, Bedaquiline)
Not yet recruiting
- Tuberculosis, Pulmonary
- Tuberculosis Infection
- Rifabutin
- +7 more
-
Denver, Colorado
- +14 more
Mar 2, 2023
Outcomes in Tuberculous Patients in Sohag Governorate
Recruiting
- Tuberculosis
- sputum analysis
- lymph node biobsy
-
Sohag, EgyptSohag university Hospital
Nov 15, 2023
Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)
Not yet recruiting
- Tuberculous Meningitis
- High dose rifampicin (25mg/kg)
- +8 more
-
Chennai, Tamil Nadu, IndiaICMR- National Institute for Research in Tuberculosis
Jun 15, 2023
Pulmonary Tuberculosis Trial in Chennai (Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol)
Completed
- Pulmonary Tuberculosis
- Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol
-
Chennai, Tamilnadu, IndiaTuberculosis Research Centre
Apr 13, 2021
Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)
Not yet recruiting
- Healthy
- H107e
- +10 more
-
Pretoria, Gauteng, South AfricaAurum Institute
Sep 24, 2023
Time-to-Detection in Culture of Mycobacterium Tuberculosis
Completed
- Pulmonary Tuberculoses
- No intervention
-
Nice, FranceNice University Hospital
Oct 4, 2022